Morrisville, NC – According to filings with the U.S. Securities and Exchange Commission, Clinipace is raising $10,007,033.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jason Monteleone played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Clinipace
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment, with an emphasis on personalized services and solutions, regulatory expertise, and therapeutic leadership. Our mission is to improve the way clinical research is performed in major therapeutic areas including oncology, rare disease, gastroenterology, nephrology, and women’s health. Clinipace strives to impact the future of drug development and health care by combining the most advanced technology and a CHALLENGE ACCEPTED approach.

To learn more about Clinipace, visit http://www.clinipace.com/

Contact:
Jason Monteleone, Chief Executive Officer
919-224-8800
https://www.linkedin.com/in/jasonmonteleone/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved